BlackRock, the world's largest investment manager, led the round, joined by new investors Deerfield Management and Moore Strategic Ventures as well as existing investors.
Formerly the data analytics division of CTCA, Vidence is supporting an immuno-oncology trial for BMS as it looks to grow its network of hospital partners.
Duality will apply homomorphic encryption to data from multiple sources to train machine learning while safeguarding the privacy of individual patients.
The startup has exclusively licensed an integration engine from the University of Miami to augment its VIPER platform and improve trial recruitment specifically in precision oncology.
Working with clinical decision support vendor ActX, the suburban Chicago health system has seen strong demand for PGx and genetically informed preventive care.
In Phase 2 pilots, four healthcare organizations helped HL7 refine its FHIR Genomics specification but uncovered many remaining hurdles to true interoperability.
